Literature DB >> 26901138

Reasons for the discontinuation of therapy of personal insulin pump in children with type 1 diabetes.

Alicja Binek1, Agnieszka Rembierz-Knoll1, Joanna Polańska2, Przemysława Jarosz-Chobot3.   

Abstract

INTRODUCTION: Pump discontinuation is rare. It is estimated that only about 4% of patients return to multiple daily injections (MDI).
OBJECTIVE: To study the factors that influence the decision to stop continuous subcutaneous insulin infusion therapy (CSII).
MATERIAL AND METHODS: Analysis of the anonymous questionnaires indicating factors that influenced pump discontinuation and return to the MDI. RESPONDENTS: 30 children (17girls), mean age 14.3yr(± 3,57), at the start of CSII 11.06yr(± 4.01), at discontinuation of pump therapy 13,23yr(±3,82).
RESULTS: The mean duration of pump usage was significantly higher in boys: 3.28yr±2.31 vs 1, 27yr±1.04(p=0.01); mean HbA1c: boys-8.03%±1.03, girls-7.78±1.42. The most frequently reported disconnection reasons were: greater sense of disease (93%), difficulties in doing sports (70%), worse well-being during pump therapy (63%), having to attach the pump to the body (60%), embarrassment (56%), adhesions and pain in the place of needle insertion (50%), difficulties in controlling glycemia during physical exercise, fear (43%), high levels of HbA1c (36%), frequent blood glucose monitoring (26%). Problems with technical operation of the pump or frequent episodes of severe hypoglycemia or ketoacidosis were not reported. Among those who indicated difficulty in controlling glycaemia during physical exercise or infection, the average age at the time of quitting the pump was significantly lower than the rest: 12.3±3.33 vs. 14.69 ±2.82 (p=0.04).
CONCLUSIONS: The individual psycho-emotional state of the child and appropriate education are important at the start and continuation of CSII. © Polish Society for Pediatric Endocrinology and Diabetology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26901138     DOI: 10.18544/PEDM-21.02.0026

Source DB:  PubMed          Journal:  Pediatr Endocrinol Diabetes Metab        ISSN: 2083-8441


  2 in total

1.  Five-Month Follow-up Shows No Improvement in Dermatological Complications in Children With Type 1 Diabetes Using Continuous Glucose Monitoring Systems and Insulin Pumps.

Authors:  Anna T Weng; Claus Zachariae; Karl B Christensen; Jannet Svensson; Anna K Berg
Journal:  J Diabetes Sci Technol       Date:  2019-10-16

Review 2.  Hypoglycaemia in type 1 diabetes: technological treatments, their limitations and the place of psychology.

Authors:  Pratik Choudhary; Stephanie A Amiel
Journal:  Diabetologia       Date:  2018-02-08       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.